University of Pittsburgh: Head and Neck Neoplasms trials

The registry lists 14 Head and Neck Neoplasms studies with University of Pittsburgh as lead sponsor. 1 are open to participants now and 3 have results posted.

Early Phase 1 2Phase 1 3Phase 2 4Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Preventing Lymphedema in Patients Undergoing Surgical Treatment for Head and Neck Cancer Through Vein ReconstructionRecruitingNCT07694726Not applicable
• Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck CancerCompletedNCT00703976Phase 2Results posted
• Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerCompletedNCT00226239Phase 2Results posted
• Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerCompletedNCT00222729Phase 2Results posted
• Enhanced Care Coordination for Head and Neck Cancer SurvivorsCompletedNCT04813172Not applicable
• Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck CancerCompletedNCT03268993Not applicable
• Measuring the Effect of Radiation Therapy on Patient Activity LevelsTerminatedNCT02694380
• Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck CancerTerminatedNCT02655068Phase 3
• Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck CancerWithdrawnNCT02593929Early Phase 1
• Pilot Study for Locally Advanced Head and Neck CancerWithdrawnNCT01262859Phase 2
• Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC FamilyCompletedNCT00779389Phase 1
• STAT3 DECOY in Head and Neck CancerCompletedNCT00696176Early Phase 1
• Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerCompletedNCT00291707Phase 1
• Gene Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00009841Phase 1